Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications

被引：26

作者：

Chapman, W. C.

Lockstadt, H.

Singla, N.

Kafie, F. E.

Lawson, J. H.

机构：

[1] Washington Univ, St Louis Sch Med, Sect Transplantat, St Louis, MO 63110 USA

[2] Orthoped Bluegrass Orthoped, Lexington, KY USA

[3] Huntington Mem Hosp, Dept Anesthesiol, Pasadena, CA USA

[4] Baptist Hosp, Dept Vasc Surg, Pensacola, FL USA

[5] Duke Univ, Med Ctr, Dept Vasc Surg, Durham, NC 27705 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 09期

关键词：

D O I：

10.1111/j.1538-7836.2006.02067.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2083 / 2085

页数：3

共 12 条

[1] Antihuman factor V antibodies after use of relatively pure bovine thrombin [J].

Lawson, JH ;

Lynn, KA ;

Vanmatre, RM ;

Domzalski, T ;

Klemp, KF ;

Ortel, TL ;

Niklason, LE ;

Parker, W .

ANNALS OF THORACIC SURGERY, 2005, 79 (03) :1037-1038

[2] The spectrum of safety: A review of the safety of current hemophilia products [J].

Luban, NLC .

SEMINARS IN HEMATOLOGY, 2003, 40 (03) :10-15

[3] Clinical perspectives of emerging pathogens in bleeding disorders [J].

Ludlam, CA ;

Powderly, WG ;

Bozzette, S ;

Diamond, M ;

Koerper, MA ;

Kulkarni, K ;

Ritchie, B ;

Siegel, J ;

Simmonds, P ;

Stanley, S ;

Tapper, ML ;

von Depka, M .

LANCET, 2006, 367 (9506) :252-261

[4] Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products [J].

Mire-Sluis, AR ;

Barrett, YC ;

Devanarayan, V ;

Koren, E ;

Liu, H ;

Maia, M ;

Parish, T ;

Scott, G ;

Shankar, G ;

Shores, E ;

Swanson, SJ ;

Taniguchi, G ;

Wierda, D ;

Zuckerman, LA .

JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 289 (1-2) :1-16

[5] Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin [J].

Ortel, TL ;

Mercer, MC ;

Thames, EH ;

Moore, KD ;

Lawson, JH .

ANNALS OF SURGERY, 2001, 233 (01) :88-96

[6] Antibodies to topical bovine thrombin correlate with access thrombosis [J].

Sands, JJ ;

Nudo, SA ;

Ashford, RG ;

Moore, KD ;

Ortel, TL .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :796-801

[7] Severe coagulopathy following intraoperative use of topical thrombin [J].

Sarfati, MR ;

DiLorenzo, DJ ;

Kraiss, LW ;

Galt, SW .

ANNALS OF VASCULAR SURGERY, 2004, 18 (03) :349-351

[8] Relative purity of thrombin-based hemostatic agents used in surgery [J].

Schoenecker, JG ;

Johnson, RK ;

Fields, RC ;

Lesher, AP ;

Domzalski, T ;

Baig, K ;

Lawson, JH ;

Parker, W .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (04) :580-590

[9] Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure [J].

Streiff, MB ;

Ness, PM .

TRANSFUSION, 2002, 42 (01) :18-26

[10] Anaphylaxis from topical bovine thrombin (Thrombostat®) during haemodialysis and evaluation of sensitization among a dialysis population [J].

Wai, Y ;

Tsui, V ;

Peng, Z ;

Richardson, R ;

Oreopoulos, D ;

Tarlo, SM .

CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (12) :1730-1734

← 1 2 →